CD8A and neoplasm: This study further found that higher ferroptosis levels in CD8+ T cells enhanced their antitumor function and CD36−CD8+ T cells combined with PD-1 antibodies showed better antitumor effect and survival time, suggesting that targeting ferroptosis is a promising therapy for improving immune checkpoint blockade (ICB)-based tumor immunotherapy.